Healthcare >> CEO Interviews >> January 24, 2011
Dr. Ian D. Gilham, Ph.D., joined the board of Axis-Shield plc in November 2001 from GlaxoSmithKline (GSK), where he held the position of Vice President, Pharmacogenetics. At GSK, he was responsible for the delivery of pharmacogenetic tests, as well as novel diagnostic tests used in targeting GSK's medicines. Prior to joining GSK, Dr. Gilham held international general management, marketing, business development and R&D positions with Abbott Laboratories, Celltech and Amersham, gaining wide expertise in the fields of pharmaceuticals and clinical diagnostics. In January 2007, Dr. Gilham was appointed Chief Operating Officer, and he was promoted to Chief Executive Officer in January 2008. Profile
TWST: Please start with a short history of Axis-Shield and a brief overview of your operations.
Dr. Gilham: I'll start with the second part. We're an in-vitro diagnostics company, so we're interested
